Geniposide protects against acute alcohol-induced liver injury in mice via up-regulating the expression of the main antioxidant enzymes

Canadian Journal of Physiology and Pharmacology

Volumn 93, Issue 4, 2015, Pages 261-267

  Wang, Junming ^a,b   Zhang, Yueyue ^a   Liu, Ruixin ^a   Li, Xiaobing ^a   Cui, Ying ^a   Qu, Lingbo ^b,c  

^a HENAN UNIVERSITY OF CHINESE MEDICINE   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c HENAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Catalase; Copper and zinc containing superoxide dismutase; Gardenia jasminoides Ellis; Hepatoprotection; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; BIFENDATE; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GENIPOSIDE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; LIPID; LIVER PROTECTIVE AGENT; MESSENGER RNA; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; IRIDOID; OXIDOREDUCTASE; PROTECTIVE AGENT; SUPEROXIDE DISMUTASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER CIRRHOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME INDUCTION; GENE EXPRESSION; LIPID PEROXIDATION; LIVER LEVEL; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; AGONISTS; ANIMAL; BLOOD; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; GENETICS; INBRED MOUSE STRAIN; LIVER; LIVER DISEASES, ALCOHOLIC; METABOLISM; OXIDATIVE STRESS; RANDOMIZATION;

ANIMALS; BIOMARKERS; CATALASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; IRIDOIDS; LIPID PEROXIDATION; LIVER; LIVER DISEASES, ALCOHOLIC; MALE; MICE, INBRED STRAINS; OXIDATIVE STRESS; OXIDOREDUCTASES; PROTECTIVE AGENTS; RANDOM ALLOCATION; RNA, MESSENGER; SUPEROXIDE DISMUTASE;

EID: 84925348946     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2014-0536     Document Type: Article

References (36)

1. Aebi, H. 1984. Catalse in vitro. Methods Enzymol. 105: 121–126. doi:10.1016/S0076-6879(84)05016-3. PMID:6727660.
2. Bocchetti, R., and Regoli, F. 2006. Seasonal variability of oxidative biomarkers, lysosomal parameters, metallothioneins and peroxisomal enzymes in the Mediterranean mussel Mytilus galloprovincialis from Adriatic Sea. Chemosphere, 65(6): 913–921. doi:10.1016/j.chemosphere.2006.03.049. PMID:16678235.
3. Carbonell, L.F., Nadal, J.A., Llanos, M.C., Hernández, I., Nava, E., and Díaz, J. 2000. Depletion of liver glutathione potentiates the oxidative stress and decreases nitric oxide synthesis in a rat endotoxin shock model. Crit. Care Med. 28(6): 2002–2006. doi:10.1097/00003246-200006000-00054. PMID:10890655.
4. Diluzio, N.R. 1964. Prevention of the acute ethanol-induced fatty liver by the simultaneous administration of antioxidants. Life Sci. 3: 113–118. doi:10.1016/0024-3205(64)90189-4. PMID:14148131.
5. Du, J., He, D., Sun, L.N., Han, T., Zhang, H., Qin, L.P., and Rahman, K. 2010. Semen hoveniae extract protects against acute alcohol-induced liver injury in mice. Pharm. Biol. 48(8): 953–958. doi:10.3109/13880200903300196. PMID:20673184.
6. El Mouatassim, S., Guérin, P., and Ménézo, Y. 1999. Expression of genes encoding antioxidant enzymes in human and mouse oocytes during the final stages of maturation. Mol. Hum. Reprod. 5(8): 720–725. doi:10.1093/molehr/5.8.720. PMID:10421798.
7. Frazier, T.H., Stocker, A.M., Kershner, N.A., Marsano, L.S., and McClain, C.J. 2011. Treatment of alcoholic liver disease. Therap. Adv. Gastroenterol. 4(1): 63–81. doi:10.1177/1756283X10378925. PMID:21317995.
8. Galligan, J.J., Fritz, K.S., Backos, D.S., Shearn, C.T., Smathers, R.L., Jiang, H., et al. 2014. Oxidative stress-mediated aldehyde adduction of GRP78 in a mouse model of alcoholic liver disease: Functional independence of ATPase activity and chaperone function. Free Radic. Biol. Med. 73: 411–420. doi:10.1016/j.freeradbiomed.2014.06.002. PMID:24924946.
9. Grasselli, E., Compalati, A.D., Voci, A., Vecchione, G., Ragazzoni, M., Gallo, G., et al. 2014. Altered oxidative stress/antioxidant status in blood of alcoholic subjects is associated with alcoholic liver disease. Drug Alcohol Depend. 143:112–119. doi:10.1016/j.drugalcdep.2014.07.013. PMID:25107314.
10. Habig, W.H., and Jakoby, W.B. 1981. Assay for differentiation of glutathione S-transferases. Methods Enzymol. 77: 398–405. doi:10.1016/S0076-6879(81)77053-8. PMID:7329316.
11. Han, D., Hanawa, N., Saberi, B., and Kaplowitz, N. 2006. Mechanisms of liver injury. III. Role of glutathione redox status in liver injury. Am. J. Physiol. Gastrointest. Liver Physiol. 291(1): G1–G7. doi:10.1152/ajpgi.00001.2006. PMID:16500922.
12. Hassan, L., Bueno, P., Ferrón-Celma, I., Ramia, J.M., Garrote, D., Muffak, K., et al. 2005. Time course of antioxidant enzyme activities in liver transplant recipients. Transplant. Proc. 37(9): 3932–3935. doi:10.1016/j.transproceed.2005.10.088. PMID:16386589.
13. Hogberg, J., Larson, R.E., Kristoferson, A., and Orrenius, S. 1974. NADPH-dependent reductase solubilized from microsomes by peroxidation and its activity. Biochem. Biophys. Res. Commun. 56(3): 836–842. doi:10.1016/0006-291X(74)90681-0. PMID:4151195.
14. Hougardy, B.M., van der Zee, A.G., van den Heuvel, F.A., Timmer, T., de Vries, E.G., and de Jong, S. 2005. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: Relationship with Fas, caspase-8, and Bid. Gynecol. Oncol. 97(2): 353–364. doi:10.1016/j.ygyno.2005.01.036. PMID:15863130.
15. Kamei, T., Asano, K., and Nakamura, S. 1986. Determination of serum glutamate oxaloacetate transaminase and glutamate pyruvate transaminase by using L-glutamate oxidase. Chem. Pharm. Bull. 34(1): 409–412. doi:10.1248/cpb.34.409. PMID:2870817.
16. Kim, J., Kim, H.Y., and Lee, S.M. 2013. Protective effects of geniposide and genipin against hepatic ischemia/reperfusion injury in mice. Biomol. Ther. (Seoul), 21(2): 132–137. doi:10.4062/biomolther.2013.005. PMID:24009871.
17. Li, Y.M. 2010. The epidemiology and natural history of alcoholic liver disease. Zhonghua Gan Zang Bing Za Zhi, 18(3): 171–172. doi:10.3760/cma.j.issn.1007-3418.2010.03.004. PMID:20380789.
18. Liang, Q.N., Sheng, Y.C., Jiang, P., Ji, L.L., Xia, Y.Y., Min, Y., and Wang, Z.T. 2011. The difference of glutathione antioxidant system in newly weaned and young mice liver and its involvement in isoline-induced hepatotoxicity. Arch. Toxicol. 85(10): 1267–1279. doi:10.1007/s00204-011-0664-7. PMID:21327617.
19. Liu, J., Yin, F., Zheng, X., Jing, J., and Hu, Y. 2007. Geniposide, a novel agonist for GLP-1 receptor, prevents PC12 cells from oxidative damage via MAP kinase pathway. Neurochem. Int. 51(6–7): 361–369. doi:10.1016/j.neuint.2007.04.021. PMID:17629357.
20. Liu, J.H., Yin, F., Guo, L.X., Deng, X.H., and Hu, Y.H. 2009. Neuroprotection of geniposide against hydrogen peroxide induced PC12 cells injury: Involvement of PI3 kinase signal pathway. Acta Pharmacol. Sin. 30(2): 159–165. doi:10.1038/aps.2008.25. PMID:19151742.
21. Lv, C., Liu, X., Liu, H., Chen, T., and Zhang, W. 2014. Geniposide attenuates mitochondrial dysfunction and memory deficits in APP/PS1 transgenic mice. Curr. Alzheimer Res. 11(6): 580–587. doi:10.2174/1567205011666140618095925. PMID:25034042.
22. Ma, T., Huang, C., Zong, G., Zha, D., Meng, X., Li, J., and Tang, W. 2011. Hepatoprotective effects of geniposide in a rat model of nonalcoholic steatohepatitis. J. Pharm. Pharmacol. 63(4): 587–593. doi:10.1111/j.2042-7158.2011.01256.x. PMID:21401612.
23. Mandayam, S., Jamal, M.M., and Morgan, T.R. 2004. Epidemiology of alcoholic liver disease. Semin. Liver Dis. 24(3): 217–232. doi:10.1055/s-2004-832936. PMID:15349801.
24. Marklund, S.L., and Marklund, G. 1974. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47(3): 469–474. doi:10.1111/j.1432-1033.1974.tb03714.x. PMID:4215654.
25. Peskin, A.V. 1997. Cu, Zn-superoxide dismutase gene dosage and cell resistance to oxidative stress: A review. Biosci. Rep. 17(1): 85–89. doi:10.1023/A:1027343519591. PMID:9171924.
26. Polavarapu, R., Spitz, D.R., Sim, J.E., Follansbee, M.H., Oberley, L.W., Rahemtulla, A., and Nanji, A.A. 1998. Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology, 27(5): 1317–1323. doi:10.1002/hep.510270518. PMID:9581686.
27. Romero, F.J., Bosch-Morell, F., Romero, M.J., Jareño, E.J., Romero, B., Marín, N., and Romá, J. 1998. Lipid peroxidation products and antioxidants in human disease. Environ. Health Perspect. 106: 1229–1234. doi:10.2307/3433990. PMID:9788902.
28. Rotruck, J.T., Pope, A.L., Ganther, H.E., Swanson, A.B., Hafeman, D.G., and Hoekstra, W.G. 1973. Selenium: Biochemical role as a component of glutathione peroxidase. Science, 179(4073): 588–590. doi:10.1126/science.179.4073.588 PMID:4686466.
29. Rouach, H., Fataccioli, V., Gentil, M., French, S.W., Morimoto, M., and Nordmann, R. 1997. Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology. Hepatology, 25(2): 351–355. doi:10.1002/hep.510250216. PMID:9021946.
30. Sid, B., Verrax, J., and Calderon, P.B. 2013. Role of oxidative stress in the pathogenesis of alcohol-induced liver disease. Free Radic. Res. 47(11): 894–904. doi:10.3109/10715762.2013.819428. PMID:23800214.
31. Tarantino, G., Conca, P., Basile, V., Gentile, A., Capone, D., Polichetti, G., and Leo, E. 2007. A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease. Hepatol. Res. 37(6): 410–415. doi:10.1111/j.1872-034X.2007.00072.x. PMID:17539815.
32. Tarantino, G., Colao, A., Capone, D., Conca, P., Tarantino, M., Grimaldi, E., et al. 2011a. Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with nonalcoholic fatty liver disease. J. Biol. Regul. Homeost. Agents, 25(1): 47–56. PMID:21382273.
33. Tarantino, G., Scopacasa, F., Colao, A., Capone, D., Tarantino, M., Grimaldi, E., and Savastano, S. 2011b. Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease. World J. Gastroenterol. 17(48): 5280–5288. doi:10.3748/wjg.v17.i48.5280. PMID:22219597.
34. Wang, C.J., Wang, S.W., and Lin, J.K. 1991. Suppressive effect of geniposide on the hepatotoxicity and hepatic DNA binding of aflatoxin B1 in rats. Cancer Lett. 60(2): 95–102. doi:10.1016/0304-3835(91)90214-3. PMID:1682034.
35. Wang, Z., Dou, X., Li, S., Zhang, X., Sun, X., Zhou, Z., and Song, Z. 2014. Nuclear factor (erythroid-derived 2)-like 2 activation-induced hepatic very-low-density lipoprotein receptor overexpression in response to oxidative stress contributes to alcoholic liver disease in mice. Hepatology, 59(4): 1381–1392. doi:10.1002/hep.26912. PMID:24170703.
36. Zelko, I.N., Mariani, T.J., and Folz, R.J. 2002. Superoxide dismutase multigene family: A comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic. Biol. Med. 33(3): 337–349. doi:10.1016/S0891-5849(02)00905-X. PMID:12126755.